Drug Metabolism Reviews
IF
3.96
Papers
1383
Papers 1444
1 page of 145 pages (1,444 results)
Newest
#1Aarzoo Thakur (Agency for Science, Technology and Research)H-Index: 1
Last. Chukwunonso K NwabufoH-Index: 1
view all 8 authors...
A reliable, rapid, and effective bioanalytical method is essential for the determination of the pharmacokinetic, pharmacodynamic, and toxicokinetic parameters that inform the safety and efficacy profile of investigational drugs. The overall goal of bioanalytical method development is to elucidate the procedure and operating conditions under which a method can sufficiently extract, qualify, and/or quantify the analyte(s) of interest and/or their metabolites for the intended purpose. Given the dif...
Source
Knowledge of the metabolic stability of a new drug substance eliminated by biotransformation is essential for envisaging the pharmacokinetic parameters required for deciding drug dosing and frequency. Strategies aimed at modifying lead compounds may improve metabolic stability, thereby reducing the drug dosing frequency. Replacement of selective hydrogens with deuterium can effectively enhance the drug's metabolic stability by increasing the biological half-life. Further, cyclization, change in ...
Source
#1Paresh P. Chothe (Takeda Pharmaceutical Company)
#2Masanori Nakakariya (Takeda Pharmaceutical Company)H-Index: 10
Last. Kimio Tohyama (Takeda Pharmaceutical Company)H-Index: 7
view all 5 authors...
Drug Metabolism Reviews has an impressive track record of providing scientific reviews in the area of xenobiotic biotransformation over 47 years. It has consistently proved to be resourceful to many scientists from pharmaceutical industry, academia, regulatory agencies working in diverse areas including enzymology, pharmacology, pharmacokinetics and toxicology. Over the last 5 years Drug metabolism Reviews has annually published an industry commentary aimed to highlight novel insights and approa...
Source
#1R H Wilson (UW: University of Wisconsin-Madison)
#1Rachel H Wilson (UW: University of Wisconsin-Madison)H-Index: 1
Last. C A Bradfield (UW: University of Wisconsin-Madison)
view all 2 authors...
The aryl hydrocarbon receptor (AHR) is a ligand activated transcription factor that is a member of the PER-ARNT-SIM superfamily of environmental sensors. This receptor has been a molecule of interest for many years in the field of toxicology, as it was originally discovered to mediate the toxic effects of certain environmental pollutants like benzo(a)pyrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin. While all animals express this protein, there is naturally occurring variability in receptor size a...
Source
#1S. Cyrus Khojasteh (Genentech)H-Index: 18
#2Upendra A. Argikar (Novartis)H-Index: 16
Last. Cong Wei (Biogen Idec)
view all 14 authors...
This annual review is the sixth of its kind since 2016 (see references). Our objective is to explore and share articles which we deem influential and significant in the field of biotransformation and bioactivation. These fields are constantly evolving with new molecular structures and discoveries of corresponding pathways for metabolism that impact relevant drug development with respect to efficacy and safety. Based on the selected articles, we created three sections: (1) drug design, (2) metabo...
Source
#1Hamidreza Khodajou-Masouleh (Kharazmi University)
#2S. Shirin Shahangian (University of Gilan)H-Index: 8
Last. Behnam Rasti (IAU: Islamic Azad University)H-Index: 11
view all 3 authors...
Developing effective strategies to confront coronavirus disease 2019 (COVID-19) has become one of the greatest concerns of the scientific community. In addition to the vast number of global mortalities due to COVID-19, since its outbreak, almost every aspect of human lives has changed one way or another. In the present review, various defensive and offensive strategies developed to confront COVID-19 are illustrated. The Administration of immune-boosting micronutrients/agents, as well as the inhi...
Source
Drug-drug interactions mediated by transporters are a serious clinical concern hence a tremendous amount of work has been done on the characterization of the transporter-mediated proteins in humans and animals. The underlying mechanism for the transporter-mediated drug-drug interaction is the induction or inhibition of transporter which is involved in the cellular uptake and efflux of drugs. Transporter of the brain, liver, kidney, and intestine are major determinants that alter the absorption, ...
Source
#1Nikhilesh V Dhuria (UNMC: University of Nebraska Medical Center)
#2Bianka Haro (GW: George Washington University)
Last. Jasleen K. Sodhi (UCSF: University of California, San Francisco)H-Index: 9
view all 8 authors...
As lead optimization efforts have successfully reduced metabolic liabilities due to cytochrome P450 (CYP)- mediated metabolism, there has been an increase in the frequency of involvement of non-CYP enzymes in the metabolism of investigational compounds. Although there have been numerous notable advancements in the characterization of non-CYP enzymes with respect to their localization, reaction mechanisms, species differences and identification of typical substrates, accurate prediction of non-CY...
Source
#1Jaydeep Yadav (MSD: Merck & Co.)
#2Mehdi El Hassani (UdeM: Université de Montréal)
Last. Laura E RussellH-Index: 3
view all 6 authors...
Improved PK/PD prediction in early stages of drug development is essential to inform lead optimization strategies and reduce attrition rates. Recently, there have been significant advancements in the development of new in vitro and in vivo strategies to better characterize pharmacokinetic properties and efficacy of drug leads. Herein, we review advances in experimental and mathematical models for clearance predictions, advancements in developing novel tools to capture slowly metabolized drugs, i...
Source
#1Laura E RussellH-Index: 3
#2Yitian Zhou (KI: Karolinska Institutet)H-Index: 10
Last. Volker M. Lauschke (KI: Karolinska Institutet)H-Index: 30
view all 6 authors...
Pharmacogenetic research has resulted in the identification of a multitude of genetic variants that impact drug response or toxicity. These polymorphisms are mostly common and have been included as actionable information in the labels of numerous drugs. In addition to common variants, recent advances in Next Generation Sequencing (NGS) technologies have resulted in the identification of a plethora of rare and population-specific pharmacogenetic variations with unclear functional consequences tha...
1 CitationsSource
12345678910
Top fields of study
Chemistry
Biochemistry
Metabolism
Biology
Drug metabolism
Pharmacology